J. Martı́n

发表

Predictors of quality of life in patients with eating disorders

A. Loroño, Á. Padierna, J. M. Quintana, 2017, European Psychiatry.

The effectiveness of combining lithium with olanzapine in the treatment of resistant schizophrenia.

J. Martı́n, R. Perez, G. Palenciano, 2000, The Journal of clinical psychiatry.

Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.

M. Cuesta, M. Gurpegui, E. Álvarez, 1997, The Journal of clinical psychiatry.

Pharmacoeconomic Assessment of Olanzapine in the Treatment of Refractory Schizophrenia Based on a Pilot Clinical Study

J. Sacristán, V. Peralta, M. Gurpegui, 1998, Clinical drug investigation.

Treatment of resistant schizophrenia with valproate and neuroleptic drugs.

Á. Moríñigo, J. Martín, S. González, 1989, The Hillside journal of clinical psychiatry.

Evaluation of the psychometric characteristics of the Spanish version of the Anorectic Behaviour Observation Scale

Á. Padierna, J. M. Quintana, N. González, 2014, International journal of clinical practice.

Impact of interdisciplinary treatment on physical and psychosocial parameters in patients with fibromyalgia: results of a randomised trial

Josune Martín, Á. Padierna, J. M. Quintana, 2014, International journal of clinical practice.

Quality of life and economic impact of refractory epilepsy in Spain: the ESPERA study.

V. Villanueva, J. M. Girón, L. Hernández-Pastor, 2013, Neurologia.

[Prediction of violent behavior in schizophrenic inpatients].

Á. Moríñigo, J. Martı́n, D. Noval, 2000, Actas espanolas de psiquiatria.